SCHEMBL10024708

SCHEMBL10024708

CC[C@H]1O[C@@H](n2cnc(N)nc2=O)C(OC(=O)c2ccccc2)[C@H]1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
DNMT1 P26358 2/20 0.47
HTT P42858 2/20 0.47
GMNN O75496 1/20 0.47
LMNA P02545 1/20 0.47
TP53 P04637 1/20 0.47
NFKB1 P19838 1/20 0.47
THPO P40225 1/20 0.47
MTOR P42345 1/20 0.47
RAB9A P51151 1/20 0.47
BLM P54132 1/20 0.47
HBB P68871 1/20 0.47
PMP22 Q01453 1/20 0.47
P2RX3 P56373 2/20 0.43
P2RX4 Q99571 2/20 0.43
P2RX2 Q9UBL9 2/20 0.43
P2RY11 Q96G91 2/20 0.43
POLB P06746 2/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10024704 0.86 LMNA (0.52) ALDH1A1DNMT1HTTGMNNLMNA
SCHEMBL14549613 0.86 LMNA (0.52) ALDH1A1DNMT1HTTGMNNLMNA
SCHEMBL26808476 0.84 P2RY11 (0.48) ALDH1A1LMNATP53P2RX3P2RX4
SCHEMBL17464581 0.84 P2RY11 (0.48) ALDH1A1LMNATP53P2RX3P2RX4
SCHEMBL15837358 0.84 P2RY11 (0.48) ALDH1A1LMNATP53P2RX3P2RX4
SCHEMBL27055211 0.84 CDA (0.44) ALDH1A1HTTP2RX3P2RX4P2RX2
SCHEMBL25824039 0.84 CDA (0.44) ALDH1A1HTTP2RX3P2RX4P2RX2
SCHEMBL784542 0.83 TAS1R3 (0.55) P2RX3P2RX4P2RX2P2RY11TAS1R3
SCHEMBL26808474 0.83 TAS1R3 (0.55) P2RX3P2RX4P2RX2P2RY11TAS1R3
SCHEMBL13376162 0.83 MEN1 (0.58) ALDH1A1DNMT1HTTGMNNLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120029181-A1 SYNTHESIS OF 5-AZACYTIDINE PHARMION LLC (US) 2012-02-02 US disclosed
US-8058424-B2 Synthesis of 5-azacytidine PHARMION LLC (US) 2011-11-15 US disclosed
US-20110092694-A1 SYNTHESIS OF 5-AZACYTIDINE PHARMION LLC 2011-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110092694-A1 SYNTHESIS OF 5-AZACYTIDINE TYMS, DNMT1, TET1 ALDH1A1 2154/4885DNMT1 2/4885HTT 2279/4885
US-20120029181-A1 SYNTHESIS OF 5-AZACYTIDINE TYMS, DNMT1, TET1 ALDH1A1 2154/4885DNMT1 2/4885HTT 2279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.